DK713488D0 - Adenosinderivater - Google Patents

Adenosinderivater

Info

Publication number
DK713488D0
DK713488D0 DK713488A DK713488A DK713488D0 DK 713488 D0 DK713488 D0 DK 713488D0 DK 713488 A DK713488 A DK 713488A DK 713488 A DK713488 A DK 713488A DK 713488 D0 DK713488 D0 DK 713488D0
Authority
DK
Denmark
Prior art keywords
adenosine
Prior art date
Application number
DK713488A
Other languages
English (en)
Other versions
DK713488A (da
DK170894B1 (da
Inventor
Brian Evans
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK713488D0 publication Critical patent/DK713488D0/da
Priority to GB898914344A priority Critical patent/GB8914344D0/en
Publication of DK713488A publication Critical patent/DK713488A/da
Application granted granted Critical
Publication of DK170894B1 publication Critical patent/DK170894B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK713488A 1987-12-23 1988-12-21 Adenosinderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende forbindelserne samt anvendelse af forbindelserne DK170894B1 (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB898914344A GB8914344D0 (en) 1988-12-21 1989-06-22 Compounds and compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8729994 1987-12-23
GB878729994A GB8729994D0 (en) 1987-12-23 1987-12-23 Chemical compounds

Publications (3)

Publication Number Publication Date
DK713488D0 true DK713488D0 (da) 1988-12-21
DK713488A DK713488A (da) 1989-06-24
DK170894B1 DK170894B1 (da) 1996-03-04

Family

ID=10628947

Family Applications (1)

Application Number Title Priority Date Filing Date
DK713488A DK170894B1 (da) 1987-12-23 1988-12-21 Adenosinderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende forbindelserne samt anvendelse af forbindelserne

Country Status (36)

Country Link
US (1) US5032583A (da)
EP (1) EP0322242B1 (da)
JP (1) JP2736088B2 (da)
KR (1) KR890009967A (da)
CN (1) CN1024198C (da)
AT (1) ATA315488A (da)
AU (2) AU612747B2 (da)
BE (1) BE1002167A5 (da)
CA (1) CA1320195C (da)
CH (1) CH677495A5 (da)
CZ (1) CZ403991A3 (da)
DE (2) DE3856154T2 (da)
DK (1) DK170894B1 (da)
ES (1) ES2012927A6 (da)
FI (1) FI90429C (da)
FR (1) FR2629715B1 (da)
GB (2) GB8729994D0 (da)
GR (1) GR1000307B (da)
HK (1) HK1009650A1 (da)
HU (1) HU203364B (da)
IE (1) IE61302B1 (da)
IL (1) IL88765A (da)
IT (1) IT1224840B (da)
LU (1) LU87414A1 (da)
MX (1) MX14331A (da)
NL (1) NL8803140A (da)
NO (1) NO171506C (da)
NZ (1) NZ227485A (da)
PH (1) PH25932A (da)
PL (1) PL158800B1 (da)
PT (1) PT89328B (da)
RU (2) RU1826971C (da)
SE (1) SE8804609L (da)
SG (1) SG44701A1 (da)
YU (1) YU234188A (da)
ZA (1) ZA889593B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2226027B (en) * 1988-12-13 1992-05-20 Sandoz Ltd Adenosine derivatives,their production and use
FR2665362B1 (fr) * 1990-08-03 1994-12-09 Cepbepe Substance contenant, comme principe actif, une adenosine substitutee en n6 et son application.
CA2092305C (en) * 1990-09-25 2003-02-11 Alfred P. Spada Compounds having antihypertensive and anti-ischemic properties
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
GB9111580D0 (en) * 1991-05-30 1991-07-24 Wellcome Found Nucleoside derivative
DK62692D0 (da) * 1992-05-14 1992-05-14 Novo Nordisk As
US5672588A (en) * 1992-05-20 1997-09-30 Novo Nordisk A/S Purine derivatives
US5443836A (en) * 1993-03-15 1995-08-22 Gensia, Inc. Methods for protecting tissues and organs from ischemic damage
CZ327896A3 (en) * 1994-05-10 1997-03-12 Sandoz Ltd Adenosine derivatives, process of their preparation, the use of said derivatives for preparing medicaments, the derivatives used for therapy and pharmaceutical composition containing thereof
GB9421133D0 (en) * 1994-10-20 1994-12-07 Glaxo Group Ltd Medicaments
WO1997033591A1 (en) * 1996-03-13 1997-09-18 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
AU2022497A (en) * 1996-03-13 1997-10-01 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
US6376472B1 (en) * 1996-07-08 2002-04-23 Aventis Pharmaceuticals, Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US6878716B1 (en) 1998-06-02 2005-04-12 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptor and uses thereof
US6686366B1 (en) 1998-06-02 2004-02-03 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
WO1999062518A1 (en) 1998-06-02 1999-12-09 Osi Pharmaceuticals, Inc. PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE
US6784165B1 (en) * 1999-11-23 2004-08-31 Aderis Pharmaceuticals, Inc. Treatment of heart rhythm disturbances with N6-substituted-5′-(N-substituted) carboxamidoadenosines
US6664252B2 (en) 1999-12-02 2003-12-16 Osi Pharmaceuticals, Inc. 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
US6680322B2 (en) 1999-12-02 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US7160890B2 (en) 1999-12-02 2007-01-09 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6294522B1 (en) * 1999-12-03 2001-09-25 Cv Therapeutics, Inc. N6 heterocyclic 8-modified adenosine derivatives
GB9930083D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
GB9930077D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
US6680324B2 (en) 2000-12-01 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US6673802B2 (en) 2000-12-01 2004-01-06 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
GB0106867D0 (en) 2001-03-20 2001-05-09 Glaxo Group Ltd Process
EP1258247A1 (en) * 2001-05-14 2002-11-20 Aventis Pharma Deutschland GmbH Adenosine analogues for the treatment of insulin resistance syndrome and diabetes
DK1450811T3 (da) 2001-11-30 2010-02-15 Osi Pharm Inc Forbindelser specifikke af adenosin A1- og A3-receptorer og anvendelser heraf
ATE458483T1 (de) 2001-12-20 2010-03-15 Osi Pharm Inc Selektive pyrimidin-a2b-antagonistenverbindungen, ihre synthese und verwendung
DE60236458D1 (de) 2001-12-20 2010-07-01 Osi Pharm Inc Pyrrolopyrimidin a2b selektive antagonistische verbindungen, deren synthese und verwendung
WO2004100964A1 (en) * 2003-04-24 2004-11-25 Aderis Pharmaceuticals, Inc. Method of treating atrial fibrillation or atrial flutter
TWI494102B (zh) * 2003-05-02 2015-08-01 Japan Tobacco Inc 包含s-〔2(〔〔1-(2-乙基丁基)環己基〕羰基〕胺基)苯基〕2-甲基丙烷硫酯及hmg輔酶a還原酶抑制劑之組合
WO2005025545A2 (en) * 2003-09-17 2005-03-24 Aderis Pharmaceuticals, Inc. Pharmaceutical formulation for controlled release of selodenoson
AU2006320578B2 (en) * 2005-11-30 2013-01-31 Inotek Pharmaceuticals Corporation Purine derivatives and methods of use thereof
CN101712709A (zh) * 2008-10-06 2010-05-26 中国医学科学院药物研究所 三乙酰基-3-羟基苯基腺苷及其调血脂的用途
CA2772258C (en) 2009-08-31 2017-11-21 Lonza Ltd Process for the preparation of (1s,4r)-2-oxa-3-azabicyclo[2,2.1]hept-5-enes
TWI677489B (zh) 2014-06-20 2019-11-21 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130136C (da) * 1966-10-20
NL6717061A (da) * 1966-12-21 1968-06-24
DE2052596A1 (de) * 1970-10-27 1972-05-04 Boehringer Mannheim Gmbh, 6800 Mannheim Neuartige Verwendung von N(6)-substituierten Adenosin-Derivaten
NL7203984A (da) * 1971-04-10 1972-10-12
BE788958A (fr) * 1971-09-18 1973-03-19 Schering Ag Derives d'adenosine et leur procede de preparation
DE2148838A1 (de) * 1971-09-30 1973-04-05 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2157036A1 (de) * 1971-11-17 1973-05-24 Boehringer Mannheim Gmbh Neue heterocyclisch substituierte nebularin-derivate und verfahren zu deren herstellung
DE2244328A1 (de) * 1972-09-09 1974-03-21 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2338705A1 (de) * 1973-07-31 1975-02-13 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2338963A1 (de) * 1973-08-01 1975-02-13 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2426682A1 (de) * 1974-06-01 1975-12-11 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
AU579412B2 (en) * 1984-10-26 1988-11-24 Warner-Lambert Company N` - substituted adenosines
ZA857998B (en) * 1984-10-26 1986-05-28 Warner Lambert Co N6-substituted adenosines

Also Published As

Publication number Publication date
JP2736088B2 (ja) 1998-04-02
EP0322242A3 (en) 1990-04-18
CN1024198C (zh) 1994-04-13
IL88765A (en) 1993-04-04
PL276697A1 (en) 1990-02-19
HUT48903A (en) 1989-07-28
FR2629715A1 (fr) 1989-10-13
NO171506C (no) 1993-03-24
DE3856154D1 (de) 1998-05-07
NZ227485A (en) 1991-06-25
GB2212498B (en) 1991-07-24
CA1320195C (en) 1993-07-13
GR1000307B (el) 1992-05-12
EP0322242B1 (en) 1998-04-01
RU1826971C (ru) 1993-07-07
ES2012927A6 (es) 1990-04-16
HU203364B (en) 1991-07-29
FI885943L (fi) 1989-06-24
IE61302B1 (en) 1994-10-19
GB8829983D0 (en) 1989-02-15
DK713488A (da) 1989-06-24
EP0322242A2 (en) 1989-06-28
KR890009967A (ko) 1989-08-05
GB8729994D0 (en) 1988-02-03
ZA889593B (en) 1989-09-27
IT8848714A0 (it) 1988-12-23
SE8804609L (sv) 1989-06-24
IL88765A0 (en) 1989-07-31
ATA315488A (de) 1994-02-15
FI90429B (fi) 1993-10-29
GB2212498A (en) 1989-07-26
MX14331A (es) 1993-12-01
AU8589491A (en) 1991-12-12
CH677495A5 (da) 1991-05-31
SE8804609D0 (sv) 1988-12-21
YU234188A (en) 1990-12-31
SG44701A1 (en) 1997-12-19
LU87414A1 (fr) 1989-07-07
FI90429C (fi) 1994-02-10
IT1224840B (it) 1990-10-24
FR2629715B1 (fr) 1993-09-03
NO885719D0 (no) 1988-12-22
US5032583A (en) 1991-07-16
JPH01203400A (ja) 1989-08-16
DE3856154T2 (de) 1998-08-27
PL158800B1 (en) 1992-10-30
DE3843609A1 (de) 1989-07-06
BE1002167A5 (fr) 1990-08-28
CN1035295A (zh) 1989-09-06
HK1009650A1 (en) 1999-06-04
IE883845L (en) 1989-06-23
NL8803140A (nl) 1989-07-17
PT89328B (pt) 1993-08-31
AU2740188A (en) 1989-06-29
NO885719L (no) 1989-06-26
PT89328A (pt) 1989-12-29
PH25932A (en) 1991-12-19
NO171506B (no) 1992-12-14
DK170894B1 (da) 1996-03-04
AU612747B2 (en) 1991-07-18
RU2060996C1 (ru) 1996-05-27
CZ403991A3 (en) 1993-04-14

Similar Documents

Publication Publication Date Title
DK713488D0 (da) Adenosinderivater
ATA30988A (de) Alpinski
ATA174488A (de) Alpinski
DK564088A (da) Nukleosidderivater
ATA174288A (de) Alpinski
ATA224788A (de) Calcitoninsuppositorien
DK626989D0 (da) Adenosinderivater
BR8705012A (pt) Mini-persiana
AT389045B (de) Paraocclusaler loeffel
ATA48687A (de) Guellefass
ATA294988A (de) Haecksler
ATA282287A (de) Antivirale 8-phenylxanthine
ATA162787A (de) Hoergeraet
AT388649B (de) Sportschuh
BR6701228U (pt) Poltrona-cama
BR8700074A (pt) Diagramador
BR6700856U (pt) Micro-semeador
BR6700994U (pt) Isqueiro-cinzeiro
BR6701063U (pt) Cesta-cofre
BR6701551U (pt) Metro-esquadro-profissional
BR6701645U (pt) Prendedor-cabide
BR6701671U (pt) Dessensibilizador
BR6701723U (pt) Nivel-atmosfera-profissional
BR6701734U (pt) Amnioscopio
BR6701938U (pt) Multi-escada

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed